Moleculera Biosciences Press Releases

Published on October 1, 2025 - 12:00 GMT

Moleculera Biosciences advances first-of-its-kind biomarker panel for Alzheimer’s through alliance with Lunai Bioworks

Leveraging biomarkers, personal history measures and advanced AI platform to develop test that detects Alzheimer’s disease prior to symptom onset and diagnosis OKLAHOMA CITY, OK, UNITED STATES, October 1, 2025 /⁨EINPresswire.com⁩/ -- Moleculera …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on April 16, 2025 - 12:15 GMT

Moleculera Biosciences Appoints Dr. Michael Rossbach to its Advisory Board as International Commercial Strategy Advisor

Newly appointed advisor to assist in the company’s international expansion and growth OKLAHOMA CITY, OK, UNITED STATES, April 16, 2025 /⁨EINPresswire.com⁩/ -- Moleculera Biosciences, a precision medicine company focused on uncovering the immune-mediated …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on March 20, 2025 - 12:00 GMT

Moleculera Biosciences names Rod Whitson as Strategic Advisor for Growth and Implementation

Moleculera, a precision medicine company, expands Advisory Board as it enters a new phase of accelerated growth, market expansion and operational scaling. OKLAHOMA CITY, OK, UNITED STATES, March 20, 2025 /⁨EINPresswire.com⁩/ -- Moleculera Biosciences, a …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on October 30, 2024 - 12:15 GMT

Moleculera Biosciences Awarded $500K Grant to Clinically Validate Immune-mediated Cardiovascular Disorder Biomarkers

Precision medicine blood panel to aid in diagnosing and treating patients with myocarditis, cardiomyopathy, and chronic heart failure due to immune dysfunction OKLAHOMA CITY, OK, UNITED STATES, October 30, 2024 /⁨EINPresswire.com⁩/ -- Moleculera …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on September 10, 2024 - 12:00 GMT

Moleculera Biosciences welcomes Asad Hussain as Board Advisor on Strategic Finance

Appointment will help company drive financial performance, enhance operational efficiencies, and support long-term growth objectives OKLAHOMA CITY, OK, UNITED STATES, September 10, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Biosciences, a precision medicine …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on August 22, 2024 - 12:00 GMT

Moleculera Biosciences Names B. Robert Mozayeni, MD as Medical and Clinical Advisor

Appointment will provide strategic guidance and insights as the company expands scope of work for immune-mediated disorders OKLAHOMA CITY, OK, USA, August 22, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Biosciences, Inc., a precision medicine company focused …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 30, 2024 - 12:15 GMT

Moleculera Labs announces rebrand to Moleculera Biosciences as company expands into new sectors

Rebrand aligns with precision medicine messaging for growth and expansion into additional immune-mediated disorder markets OKLAHOMA CITY, OK, USA, July 30, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Labs, a precision medicine company focused on uncovering …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 10, 2024 - 12:00 GMT

Moleculera Biosciences Names Dr. Safedin Sajo Beqaj as Clinical Laboratory Advisor

Appointment strengthens Company's Scientific and Clinical Board of Advisors as it continues to expand scope of its personalized medicine business OKLAHOMA CITY, OK, USA, July 10, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Biosciences, Inc., a precision …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on May 23, 2024 - 14:15 GMT

Moleculera Biosciences Board of Directors names Healthcare Innovator and Leader Dr. Vijay Aggarwal as Board Chair

OKLAHOMA CITY, OK, UNITED STATES, May 23, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Biosciences, Inc., a precision medicine company focused on identifying and directing treatment for immune-mediated CNS and cardiovascular disorders, has appointed long-time …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on January 17, 2024 - 13:15 GMT

Moleculera Labs Forms Strategic Collaboration with Quest Diagnostics

Companies Collaborate to Broaden Access to Moleculera's Novel Neuropsychiatric Autoantibody Testing OKLAHOMA CITY, OKLAHOMA, UNITED STATES, January 17, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Labs, Inc, a precision medicine company pioneering immune- …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on January 11, 2024 - 13:15 GMT

Moleculera Labs, Inc., Awarded $500,000 Grant Funding to Develop Predictive Treatment Algorithm

Company leveraging strategic alliance w/OKC-based General Genomics to build next-gen predictive treatment model for immune-mediated neuropsychiatric disorders OKLAHOMA CITY, OK, UNITED STATES, January 11, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Labs, Inc …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on January 3, 2024 - 13:00 GMT

Moleculera Labs Names Healthcare Industry Veteran Rodney Cotton to Board of Directors

Company readies for growth and expansion of its business to identify and improve chronic immune-mediated disorders OKLAHOMA CITY, OKLAHOMA, UNITED STATES, January 3, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Labs, Inc., an Oklahoma City-based personalized …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

The Newsroom of Moleculera Biosciences